Suppr超能文献

"Attack!" Cellular Therapies to Attack Pathogens and Tumors.

作者信息

Eiz-Vesper Britta, Bonig Halvard

机构信息

Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hanover, Germany.

Goethe University, Institute for Transfusion Medicine and Immunohematology, and German Red Cross Blood Service Baden-Württemberg-Hesse, Frankfurt, Germany.

出版信息

Transfus Med Hemother. 2025 Feb 4;52(1):1-4. doi: 10.1159/000543415. eCollection 2025 Feb.

Abstract
摘要

相似文献

1
"Attack!" Cellular Therapies to Attack Pathogens and Tumors.
Transfus Med Hemother. 2025 Feb 4;52(1):1-4. doi: 10.1159/000543415. eCollection 2025 Feb.
2
IPSC-derived CAR-NK cells for cancer immunotherapy.
Biomed Pharmacother. 2023 Sep;165:115123. doi: 10.1016/j.biopha.2023.115123. Epub 2023 Jul 4.
3
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy.
Cancers (Basel). 2022 May 1;14(9):2266. doi: 10.3390/cancers14092266.
4
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies.
J Immunol Res. 2018 Sep 17;2018:4054815. doi: 10.1155/2018/4054815. eCollection 2018.
5
FT538, iPSC-derived NK cells, enhance AML cell killing when combined with chemotherapy.
J Cell Mol Med. 2025 Jan;29(1):e70169. doi: 10.1111/jcmm.70169.
7
iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting.
Front Immunol. 2022 Feb 3;13:841107. doi: 10.3389/fimmu.2022.841107. eCollection 2022.
8
Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity.
Front Immunol. 2021 Apr 2;12:662360. doi: 10.3389/fimmu.2021.662360. eCollection 2021.
9
Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy.
Cells. 2024 Nov 29;13(23):1976. doi: 10.3390/cells13231976.
10
Designing Cancer Immunotherapies That Engage T Cells and NK Cells.
Annu Rev Immunol. 2023 Apr 26;41:17-38. doi: 10.1146/annurev-immunol-101921-044122. Epub 2022 Nov 29.

本文引用的文献

1
A convenient viral transduction based method for advanced multi-engineering of primary human (CAR) T-cells.
J Genet Eng Biotechnol. 2024 Dec;22(4):100446. doi: 10.1016/j.jgeb.2024.100446. Epub 2024 Nov 28.
2
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.
Nat Commun. 2024 Dec 3;15(1):10339. doi: 10.1038/s41467-024-54595-2.
4
Allogeneic "Off-the-Shelf" CAR T cells: Challenges and advances.
Best Pract Res Clin Haematol. 2024 Sep;37(3):101566. doi: 10.1016/j.beha.2024.101566. Epub 2024 Jul 25.
5
Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy.
JAMA Neurol. 2024 Oct 7;81(11):1187-98. doi: 10.1001/jamaneurol.2024.3324.
7
Off-the-shelf CAR-T cells could prove paradigm shifting for autoimmune diseases.
Cell. 2024 Sep 5;187(18):4826-4828. doi: 10.1016/j.cell.2024.07.056.
8
Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia.
Leukemia. 2024 Oct;38(10):2183-2195. doi: 10.1038/s41375-024-02351-2. Epub 2024 Aug 3.
9
Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO.
Transplant Cell Ther. 2024 Oct;30(10):988.e1-988.e11. doi: 10.1016/j.jtct.2024.06.022. Epub 2024 Jul 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验